2016年荷兰成年寻求庇护者对麻疹、腮腺炎、风疹、水痘、白喉、破伤风、脊髓灰质炎、甲型肝炎和乙型肝炎的免疫力
2016年对荷兰622名成年寻求庇护者进行血清学调查,检测九种疫苗可预防疾病的保护性抗体。总体血清保护率从乙型肝炎的27%到破伤风的98%不等,部分亚组保护不足,除厄立特里亚外麻疹血清保护率均低于消除所需的95%阈值。
要点
- 622名成年寻求庇护者中位年龄28岁,81%为男性,48%来自叙利亚。
- 总体血清保护率:麻疹88%、腮腺炎91%、风疹94%、水痘96%、白喉82%、破伤风98%。
- 脊髓灰质炎1型91%、2型95%、3型82%;甲型肝炎84%;乙型肝炎(抗-HBs)27%。
核心结论
- 结果表明部分亚组对某些疫苗可预防疾病的保护不足。
- 除厄立特里亚外,所有国家的麻疹血清保护率均低于消除所需的95%阈值。
- 25岁以下成人的麻疹血清流行率最低。
- 研究结果可帮助在一般情况和疫情暴发时优先为成年寻求庇护者中的易感亚组接种疫苗。
研究设计与样本
- 2016年邀请来自叙利亚、伊朗、伊拉克、阿富汗、厄立特里亚和埃塞俄比亚的寻求庇护者参与血清学调查。
- 参与者签署知情同意书、提供血样并完成问卷。
- 测量对麻疹、腮腺炎、风疹、水痘、白喉、破伤风、脊髓灰质炎1-3型和甲型及乙型肝炎的保护性抗体流行率,并按来源国和年龄组分层。
主要发现
- 622名参与者的中位年龄为28岁(四分位距:23-35),81%为男性,48%来自叙利亚。
- 总体血清保护率:麻疹88%(国家间范围83-93%),腮腺炎91%(81-95%),风疹94%(84-98%),水痘96%(92-98%),白喉82%(65-88%),破伤风98%(86-100%)。
- 脊髓灰质炎1型血清保护率91%(88-94%),2型95%(90-98%),3型82%(76-86%)。
- 甲型肝炎血清保护率84%(54-100%),乙型肝炎(抗-HBs)27%(8-42%)。
- 除厄立特里亚外,所有国家的麻疹血清保护率均低于95%阈值;25岁以下成人的麻疹血清流行率最低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Asylum seekers are a vulnerable population for contracting infectious diseases. Outbreaks occur among children and adults. In the Netherlands, asylum seeker children are offered vaccination according to the National Immunization Program. Little is known about protection against vaccine-preventable diseases (VPD) in adult asylum seekers. In this 2016 study, we assessed the immunity of adult asylum seekers against nine VPD to identify groups that might benefit from additional vaccinations. We invited asylum seekers from Syria, Iran, Iraq, Afghanistan, Eritrea and Ethiopia to participate in a serosurvey. Participants provided informed consent and a blood sample, and completed a questionnaire. We measured prevalence of protective antibodies to measles, mumps, rubella, varicella, diphtheria, tetanus, polio type 1-3 and hepatitis A and B, stratified them by country of origin and age groups. The median age of the 622 participants was 28 years (interquartile range: 23-35), 81% were male and 48% originated from Syria. Overall, seroprotection was 88% for measles (range between countries: 83-93%), 91% for mumps (81-95%), 94% for rubella (84-98%), 96% for varicella (92-98%), 82% for diphtheria (65-88%), 98% for tetanus (86-100%), 91% (88-94%) for polio type 1, 95% (90-98%) for polio type 2, 82% (76-86%) for polio type 3, 84% (54-100%) for hepatitis A and 27% for hepatitis B (anti-HBs; 8-42%). Our results indicate insufficient protection against certain VPD in some subgroups. For all countries except Eritrea, measles seroprotection was below the 95% threshold required for elimination. Measles seroprevalence was lowest among adults younger than 25 years. In comparison, seroprevalence in the Dutch general population was 96% in 2006/07. The results of this study can help prioritizing vaccination of susceptible subgroups of adult asylum seekers, in general and in outbreak situations.
引用
- Freidl GS, Tostmann A, Curvers M, et al. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016. Vaccine. 2018. PMID: 29454516. doi:10.1016/j.vaccine.2018.01.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。